The conference brings together healthcare and community oncology leaders for clinical education programs
and industry updates.

FORT MYERS, Fla., October 11, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce its annual Clinical Summit conference, which is scheduled for October 12 through October 15 at the Bellagio Hotel in Las Vegas.

The conference brings together the network’s healthcare and oncology leaders and physicians from across the nation for a multi-day event. Attendees will discuss and learn about the latest advancements in oncology that will elevate patient care, all under the central theme of ‘Collaborate, Innovate and Celebrate.’

In addition to educational sessions and informative AON and industry update breakouts, this year’s conference features guest speaker Diely Pichardo, MD, a retired hematologist-oncologist, who will deliver the interactive session on well-being and career longevity. Attendees will also earn continuing medical education credits with Dr. Neil Love’s Research to Practice CME program and have access to a clinical trial and research session provided by AON clinical research leadership.

“The Clinical Summit is an exciting event that provides a platform for learning about the latest trends, sharing knowledge and building connections with others in community oncology so that cancer care can be improved,” said Todd Schonherz, AON’s chief executive officer. “The conference fosters innovation and collaboration within our community oncology industry, and we look forward to welcoming our physicians and leaders to this year’s event.”

AON is one of the nation’s fastest-growing networks focused on ensuring the viability of community oncology. Since its inception in 2018, the company has expanded to include over 200 healthcare providers in more than 75 clinics and has a current presence in 19 states.

“This year’s theme captures the AON journey perfectly,” said Stephen “Fred” Divers, MD AON’s chief medical officer and medical oncologist at Genesis Cancer and Blood Institute, one of AON’s first partner practices to join the organization. “AON celebrated its fifth anniversary in September, and as we look back on the past five years, we reflect on the tremendous impact that collaboration and innovation have had on AON’s success. The theme ‘Collaborate, Innovate and Celebrate’ is an ode to AON and the teams who have dedicated themselves to bringing AON to where it is today.”

For more information about AON, visit www.aoncology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

AON to Ring Nasdaq’s Closing Bell on September 21, 2023, to Commemorate First Day of Trading

FORT MYERS, Fla. and LOS ANGELES, September 20, 2023 – American Oncology Network, LLC (“AON” or the “Company”), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (Nasdaq: DTOC) (“DTOC”), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the “Business Combination”).

The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC (“Nasdaq”) under the new ticker symbol “AONC” on September 21, 2023. The Business Combination was approved at a special meeting of DTOC’s stockholders on September 19, 2023.

In just five years since its inception in 2018, AON has grown to include over 1,500 employees and over 200 providers in more than 75 clinics serving over 450,000 patients nationwide. AON practices have access to fully integrated ancillary services such as a specialty pharmacy, lab and pathology, radiation therapy, and imaging. These services promote clinical coordination and seamless communication throughout all stages of the care process. AON practices deliver high-quality patient care by sharing resources and expertise across the network, providing access to leading clinical trials, staying at the forefront of clinical innovation, and advocating for their patients and the profession of community oncology.

The DTOC partnership and recent strategic investment from AEA Growth, a leading global investment firm, will help further AON’s goals of supporting community oncology practices and improving the patient experience by unlocking further growth through continuing to add new providers to the AON network, scaling ancillary services, introducing new service offerings, and expanding AON’s existing services to address the broader oncology market.

“Today is an important milestone for AON and celebrates our team’s hard work and dedication, which have been the keys to our growth and success,” said Todd Schonherz, Chief Executive Officer of AON. “AON is committed more than ever to expanding our reach and advancing cancer care in communities across the nation where too often patients experience accessibility barriers.”

“We are proud of our successful partnership with AON and look forward to seeing the company’s profound impact enable advanced treatment options, clinical research, and comprehensive care options nationwide,” said Kevin Nazemi, Chief Executive Officer of DTOC.

The combined company will continue to be led by AON’s Chief Executive Officer, Todd Schonherz; Chief Financial Officer, David Gould; and Chief Medical Officer, Dr. Stephen “Fred” Divers.

Paul Hastings LLP served as legal advisor to DTOC. Woolery & Co. PLLC and Dentons US LLP served as legal advisors to AON.

###

About American Oncology Network
The American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients. Learn more at www.aoncology.com.

About DTOC
Digital Transformation Opportunities Corp. is a blank check company, led by Kevin Nazemi, Co-Founder and former Co-CEO of Oscar Health, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. DTOC’s Board of Directors includes Kevin Nazemi, Brad Fluegel (former Chief Strategy Officer of Walgreens and Anthem), Jim Moffatt (former Vice Chairman and Global CEO of Deloitte Consulting), and Heather Zynczak (former Chief Marketing Officer of Pluralsight and Domo). DTOC is focused on businesses operating in the healthcare industry. To learn more about Digital Transformation Opportunities Corp., visit www.dtocorp.com.

About AEA Growth
AEA Growth provides technology-enabled, healthcare and software companies with flexible capital and operational resources to accelerate growth. AEA Growth targets investments in category-leading, capital-efficient businesses with strong customer advocacy.

AEA Growth is part of AEA Investors LP. AEA Investors was founded in 1968 by the Rockefeller, Mellon and Harriman family interests and S.G. Warburg & Co. as a private investment vehicle for a select group of industrial family offices with substantial assets. AEA has an extraordinary global network built over many years which includes leading industrial families, business executives and leaders; many of whom invest with AEA as active individual investors and/or join its portfolio company boards or act in other advisory roles. Today, AEA’s approximately 120 investment professionals operate globally with offices in New York, Stamford, San Francisco, London, Munich and Shanghai. The firm manages funds that have approximately $19 billion of invested and committed capital including the leveraged buyouts of middle market companies and small business companies, growth capital and private investments.

For more information, please contact:

For AON:
David Gould, Chief Financial Officer
David.Gould@aoncology.com

For DTOC:
Kyle Francis, Chief Financial Officer
kyle@dtocorp.com

Forward-Looking Statements

Certain statements in this press release are forward-looking statements. Forward-looking statements generally relate to future events including future financial or operating performance of American Oncology Network, Inc. (“New AON”). Forward-looking statements generally relate to future events or New AON’s future financial or operating performance. For example, projections of future revenue and other metrics are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by New AON and its management, are inherently uncertain and are inherently subject to risks, variability and contingencies, many of which are beyond New AON’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (2) costs related to the Business Combination; (3) changes in applicable laws or regulations; (4) the possibility that New AON may be adversely affected by other economic, business, and/or competitive factors; (5) New AON’s estimates of expenses and profitability; and (6) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in New AON’s final prospectus relating to the Business Combination dated July 18, 2023 filed with the SEC, and in subsequent filings with the SEC. New AON cautions that the foregoing list of factors is not exclusive or exhaustive and investors should not place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. If any of these risks materialize or New AON’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that New AON does not presently know or that New AON currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect New AON’s expectations, plans or forecasts of future events and views as of the date of this communication. New AON anticipates that subsequent events and developments will cause New AON’s assessments to change. However, while New AON may elect to update these forward-looking statements at some point in the future, New AON specifically disclaims any obligation to do so, unless required by applicable law. These forward-looking statements should not be relied upon as representing New AON’s assessments as of any date subsequent to the date of this communication. New AON does not give any assurance that New AON will achieve its expectations. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Since its founding, AON has expanded into 19 states and counting.

FORT MYERS, Fla., September 5, 2023 – American Oncology Network (AON), one of the fastest-growing community oncology networks in the United States, proudly celebrated its fifth anniversary, commemorating a half-decade of excellence in advancing community oncology and driving value-based care initiatives to close the cancer care gap.

“Since AON’s founding in 2018, the organization has had an unwavering commitment to ensuring the viability of community oncology, supporting diversity in and accessibility of clinical trials at a local level and delivering high-quality compassionate cancer care and services,” said Todd Schonherz, AON’s chief executive officer. “I am immensely grateful and proud of the accomplishments of the AON teams and more importantly, the positive impact we have had in the lives of cancer patients. While we celebrate our five years of operation, we also celebrate and acknowledge the incredible journeys of resilience and hope undertaken by our patients whom we are honored to serve.”

AON is an alliance of physicians and veteran healthcare leaders dedicated to ensuring the long-term success of community-based oncology. AON has grown to include over 1,500 employees, close to over 200 providers in more than 75 clinics and operates in 19 states. The organization has cultivated partnerships with key leaders in healthcare and oncology services such as RXLightning and Thyme Care, which have assisted in the network’s expansive reach to over 450,000 unique patients nationwide.

“Our unique approach and physician-led model has allowed us to grow quickly over the last few years and at an impressive speed,” said Stephen “Fred” Divers, MD AON’s chief medical officer and medical oncologist at Genesis Cancer and Blood Institute in Hot Springs, Arkansas, one of AON’s first partner practices to join the organization alongside Hematology Oncology Clinic in Baton Rouge, Louisiana. “We have continued to advocate for our patients, pushing the boundaries of cancer treatments and research to ensure we are delivering the most advanced therapies available. The network’s dedicated team of experienced oncologists and medical staff as well as the internal teams at AON work tirelessly to make a meaningful difference. Congratulations to AON on five successful years.”

Through access to centralized services such as revenue cycle management, drug purchasing, payer contracting and IT, as well as enhanced services such as pathology and oral-oncolytic pharmacy, AON practices have realized significant results in increased productivity and improved operations.

Since its inception, AON achieved the following outcomes:

• Over 390 patients enrolled in more than 100 clinical trials.
• 63,000 PET/CT scans performed.
• Close to 6,000 bone marrows performed.
• 12.8 million clinical lab tests processed. 
• Over 100,000 prescriptions filled. 
• $185 million in medication and co-pay assistance.

“AON’s accomplishments are, without a doubt, inspiring and exciting for the community oncology profession,” said Shalin R. Shah, DO, AON’s Board of Managers Chairman. “Whereas there is much work still to be done in community oncology and in closing the cancer care gap, AON is an organization that is breaking the barriers to care, improving patient care and outcomes for many patients. Congratulations to AON for their accomplishments, and cheers to another five successful years.”

“This anniversary serves as an opportunity to reflect on our accomplishments as well as recommit to continuous growth, innovation and compassionate care,” said Schonherz. “As AON embarks onto this next chapter, we do so with the determination to remain at the forefront of community oncology and steadfast in our dedication to improving outcomes for cancer patients across the nation.”

For more information about AON, visit www.aoncology.com.

###

About American Oncology Network
The American Oncology Network (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at www.aoncology.com/.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Drs. Seth Hollenbach, Nathan Littlejohn and Renee Warford commit to continue delivering high-quality, comprehensive, patient-first care to the community.

HOT SPRINGS, Ark., September 1, 2023 – American Oncology Network (AON) is pleased to announce the opening of its first urology practice, Triple Crown Urology. Urologists Seth Hollenbach, MD; Nathan Littlejohn, MD; and Renee Warford, MD, joined AON’s vast network of healthcare practices.

Triple Crown Urology serves southwest Arkansas with clinics in Hot Springs, Hot Springs Village, Camden, Mena, Benton and Arkadelphia. The practice specializes in treating diseases and complications of the male and female urinary system as well as both benign and oncologic urologic issues. The providers use the latest advanced technology and have expertise in minimally invasive surgery, including robotic surgery, endoscopy, laparoscopy, Aquablation therapy and more. By joining AON as a partner practice, Triple Crown Urology will not only be able to continue providing urology care and services but also have access to additional resources that elevate patient care.

These additional services include a referral physician portal that allows for shared patient medical charts and seamless physician communication, an in-house specialty pharmacy with home delivery of certain medications, the ability to offer intravesical chemotherapy for treating urinary tract diseases and patient financial counseling.

“The partnership with AON enables us to build upon the services we currently offer as well as improve the services and offer additional services that elevate patient care,” said Seth Hollenbach, MD, Board-certified urologist at Triple Crown Urology. “AON’s mission is aligned with our mission of delivering high-quality and compassionate patient care. Our partnership will benefit our patients, and we are honored to be part of such an esteemed network of healthcare leaders.”

“We are excited to welcome Triple Crown Urology to our network,” said Todd Schonherz, AON’s chief executive officer. “Triple Crown Urology offers advanced and innovative urology treatments and delivers care that is high quality and patient centered. We look forward to their continued success in southwest Arkansas.”

“AON is excited to expand its reach beyond oncology with Triple Crown Urology, which gives AON the opportunity to offer to another medical specialty our key patient care services such as the in-house specialty pharmacy with home delivery of prescriptions and financial counseling,” said Anthony Belott, AON’s chief development officer. “These services are essential to patient care and not exclusive to oncology, and our partnership with Triple Crown Urology demonstrates that we have resources that can help practices even outside the oncology specialty thrive.”

For more information about AON, visit www.aoncology.com/. For more information about Triple Crown Urology, visit www.TripleCrownUrology.com.

###

About American Oncology Network
The American Oncology Network (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 107 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at www.aoncology.com/.

About Triple Crown Urology
Triple Crown Urology is dedicated to being the foremost urology practice in Southwest Arkansas providing comprehensive treatment and services to men and women of all ages. We treat diseases and complications of the male and female urinary tract including urinary tract infections (UTI’s), urinary incontinence, overactive bladder, interstitial cystitis, prostatitis, enlarged prostate, kidney stones, and male and female infertility. We also treat problems with male reproductive organs, including penile implants for patients suffering with erectile dysfunction. Through compassionate care that centers around the patient, we strive to provide the best possible experience throughout the healthcare journey. Learn more at www.TripleCrownUrology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network partners with Thyme Care to provide cancer care support and navigation to patients.

FORT MYERS, Fla., July 26, 2023 – American Oncology Network, LLC (AON), one of the nation’s fastest-growing networks of community oncology practices, announced its participation in the Enhancing Oncology Model (EOM), a new value-based cancer care framework launched by the Center for Medicare and Medicaid Innovation (CMMI), to improve health outcomes and reduce total costs of care.

Cancer is one of the biggest drivers of healthcare spending, costing the United States more than $200B per year. Although patient navigation services are proven to lower cancer care costs, scaling these interventions has been difficult, if not impossible, in today’s fee-for-service environment. To address the rising costs of cancer and improve care quality, CMMI launched the EOM on July 1st, 2023, a five-year voluntary program for oncology practices.

Built on the successes of and lessons learned from its predecessor, the Oncology Care Model (OCM), EOM is indicative of an industry paradigm shift towards value-based cancer care. EOM continues to focus on improving the alignment of quality, access and cost through payment incentives for care quality, 24/7 patient-focused care navigation services and addressing health equity.

“Oncology is facing an inflection point as the industry moves toward value-based care. AON is proud to be participating in the EOM,” said AON Chief Medical Officer Stephen “Fred” Divers, MD. “We look forward to realizing the goals of EOM as a network and leading the charge toward value-based cancer care.”

AON will partner with Thyme Care to reduce the total cost and improve the quality of care for AON patients. Thyme Care is a leading value-based cancer care partner, providing comprehensive cancer care support and navigation beyond the clinic for AON patients. As part of the partnership, Thyme Care will facilitate AON’s cancer clinics located across the country to participate in the EOM.

“Thyme Care’s platform of analytics and nurse navigation will provide data-driven solutions for our team of providers to ensure that patients treated in our network will maintain access to the highest standards of oncology care in a cost-effective manner while closing gaps in the care continuum and addressing any health equity disparities,” said Divers.

The Thyme Care team serves as an extension of AON practices and offers their patients a dedicated team of nurse practitioners, oncology nurses and on-demand resource specialists who can help them navigate the clinical, emotional, psychological and social barriers to care. AON oncologists will continue to lead clinical decision-making, while Thyme Care will provide these navigation services and staff.

Additional resources and support services for transportation, housing, food, behavioral health, financial assistance and more are provided to patients and their caregivers to help reduce any barriers to care. Thyme Care’s robust data and analytics capabilities will provide continual performance monitoring insights that drive practice transformation and enable AON to make data-driven decisions when selecting their preferred risk arrangement as part of their participation in the EOM. The collaboration enables both teams to provide more efficient care, proactively identify barriers to treatment and deliver clinical interventions before a patient ends up in the emergency department.

“We’re thrilled to partner with AON’s organization of community oncologists who are at the heart of delivering cancer care and therapies in their communities. It’s an honor to work alongside them to ensure all cancer patients have access to the support and resources they deserve,” said Bobby Green, MD, co-founder, president and chief medical officer of Thyme Care. “Together with AON, we can accelerate EOM to achieve a better patient experience, better outcomes and lower costs of cancer care.”

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

About Thyme Care
Thyme Care is the leading value-based cancer care partner, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care’s approach combines a technology-enabled Care Team and seamless integration with providers, creating a hybrid collaborative care delivery model that guides and supports the entire patient journey. Thyme Care empowers over 300 oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit www.thymecare.com.

Thyme Care Contact
Kimberly Dreisinger
Thyme Care Communications
kimberly@thymecare.com